Shares of TherapeuticsMD dropped by a staggering 22.12% in 14 days from $-20.99 to $1.13 at 12:45 EST on Tuesday, after five consecutive sessions in a row of losses. NASDAQ Composite is dropping 1.09% to $13,762.59, following last session’s downward trend, This seems, up until now, an all-around negative trend exchanging session today.
TherapeuticsMD’s last close was $1.16, 143.36% under its 52-week high of $2.75.
The company’s growth estimates for the present quarter and the next is 47.6% and 47.4%, respectively.
Year-on-year quarterly revenue growth grew by 42%, now sitting on 64.87M for the twelve trailing months.
TherapeuticsMD’s Stock Yearly Top and Bottom Value
TherapeuticsMD’s stock is valued at $1.13 at 12:45 EST, way under its 52-week high of $2.75 and way above its 52-week low of $0.85.
TherapeuticsMD’s Moving Average
TherapeuticsMD’s worth is way below its 50-day moving average of $1.51 and way under its 200-day moving average of $1.46.
More news about TherapeuticsMD.